Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001567892-15-000038
Filing Date
2015-08-04
Accepted
2015-08-04 16:30:02
Documents
10
Period of Report
2015-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mnkq310-q062615.htm 10-Q 2640739
2 EXHIBIT 31.1 mnkexhibit311062615.htm EX-31.1 20005
3 EXHIBIT 31.2 mnkexhibit312062615.htm EX-31.2 20059
4 EXHIBIT 32.1 mnkexhibit321062615.htm EX-32.1 7325
  Complete submission text file 0001567892-15-000038.txt   17132411

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mnk-20150626.xml EX-101.INS 5068345
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnk-20150626.xsd EX-101.SCH 87678
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnk-20150626_cal.xml EX-101.CAL 122986
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnk-20150626_def.xml EX-101.DEF 549428
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnk-20150626_lab.xml EX-101.LAB 1066953
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnk-20150626_pre.xml EX-101.PRE 719908
Mailing Address DAMASTOWN MULHUDDART DUBLIN L2 15
Business Address DAMASTOWN MULHUDDART DUBLIN L2 15 353 1 8808180
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35803 | Film No.: 151025946
SIC: 2834 Pharmaceutical Preparations